• Home
  • Kaisha Lifesciences Pvt. Ltd.
6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 18C1
Book a meeting
24
Nov
2026
IEML, Greater Noida, Delhi
24 Nov 2026 - 26 Nov 2026
stand 9G12
Book a meeting

Kaisha Lifesciences Pvt. Ltd.

About Kaisha Lifesciences Pvt. Ltd.

Kaisha Lifesciences Pvt. Ltd. is a young and innovative pharmaceutical company that strives to bring safe, high quality and highly effective medication to patients worldwide along with improving the ease and efficiency by which healthcare workers administer its products.

  • CDMO / CMO for SVP's
  • Ready CTD Dossiers (End-to-end dossier preparation and regulatory support)
  • New Product Development Services 
  • Access to 25+ GMP Approvals through our group company next-door, Sovereign Pharma, enabling seamless and instant Dossier Filings across the Globe.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 18C1
  • PMEC India 2026

    PMEC India 2026

    IEML, Greater Noida, Delhi
    24 Nov 2026 - 26 Nov 2026
    stand 9G12
  • Country/Region:
    India
  • On CPHI since:
    2019
  • Employees:
    25 - 49
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
Contract Research Organisation
Contact info
  • 9768180570
  • Website
  • 72-73, Free Press House,Nariman Point, 400021, Mumbai, Maharashtra, India
Show contact info Hide contact info

Products from Kaisha Lifesciences Pvt. Ltd. (4)

  • Ondansetron Injection BP (4 mg/2 mL, 8mg/4mL)

    Product Ondansetron Injection BP (4 mg/2 mL, 8mg/4mL)

    CTD Dossier - Ready with Zone IVb Stability Studies Primary Container - 2 mL / 5mL USP Type 1 Glass Ampoule Pack Size - 20 Ampoules in Tray, packed in Monocarton with Insert (20 Ampoules in Monocarton) Shelf Life - 24 months (Extended Stability Data available till 36 Months) Process Type - Terminally Steri...
  • Oxytocin Injection BP (5 IU/0.5mL, 5 IU/1mL, 10 IU/1mL)

    Product Oxytocin Injection BP (5 IU/0.5mL, 5 IU/1mL, 10 IU/1mL)

    CTD Dossier - Ready with Zone IVb Stability Studies Primary Container - 1 mL USP Type 1 Glass Ampoule Pack Size - 5 Ampoules packed in Blister, 15 such Blisters packed in Monocarton with Insert (75 Ampoules in Monocarton) Shelf Life - 24 months (Extended Stability Data available till 36 Months) Process Ty...
  • Pantoprazole for Injection BP 40 mg/vial (Unit Lyophilized)

    Product Pantoprazole for Injection BP 40 mg/vial (Unit Lyophilized)

    CTD Dossier - Ready with Zone IVb Stability Studies Primary Container - 10 mL USP Type 1 Glass Vial Pack Size - 1 Vial packed in Monocarton with Insert Shelf Life - 24 months (Extended Stability Data available till 30 Months) Process Type - Aseptically Sterilized GMP Approval - EU Hungary, ANIVSA Brazil
  • Enoxaparin Sodium Injection Pre Filled Syringe with Sycure AD (20mg/0.2mL, 40mg/0.4mL, 60mg/0.6mL, 80mg/0.8mL)

    Product Enoxaparin Sodium Injection Pre Filled Syringe with Sycure AD (20mg/0.2mL, 40mg/0.4mL, 60mg/0.6mL, 80mg/0.8mL)

    Enoxaparin injection is an anticoagulant primarily indicated for the prevention of deep vein thrombosis (DVT), which can lead to life-threatening pulmonary embolisms (blood clots in the lungs).

Kaisha Lifesciences Pvt. Ltd. Resources (4)